# TTE Study of QL1706 in Recurrent/Metastatic Cervical Cancer

> **NCT07652983** · — · NOT_YET_RECRUITING · sponsor: **Qilu Hospital of Shandong University** · enrollment: 280 (estimated)

## Conditions studied

- Recurrent or Metastatic Cervical Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07652983
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2026-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07652983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07652983, "TTE Study of QL1706 in Recurrent/Metastatic Cervical Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07652983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*